Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
Adult
Male
Coronaviru
Hepatiti
Pneumonia, Viral
610
Acute respiratory failure
Hepatitis
03 medical and health sciences
0302 clinical medicine
Patients' Rooms
617
Internal Medicine
Humans
Pandemics
Aged
Retrospective Studies
Aged, 80 and over
COVID-19
Middle Aged
Im - Original
3. Good health
Coronavirus
Hospitalization
Severe acute respiratory syndrome
Italy
Liver
Emergency Medicine
Female
Coronavirus Infections
Liver Failure
DOI:
10.1007/s11739-020-02425-w
Publication Date:
2020-07-10T09:03:43Z
AUTHORS (98)
ABSTRACT
AbstractLittle is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function in 100 COVID-19 consecutive patients (median age 70 years, range 25–97; 79 males) who were admitted to our internal medicine unit in March 2020. We retrospectively assessed liver function tests, taking into account demographic characteristics and clinical outcome. A patient was considered as having liver injury when alanine aminotransferase (ALT) was > 50 mU/ml, gamma-glutamyl transpeptidase (GGT) > 50 mU/ml, or total bilirubin > 1.1 mg/dl. Spearman correlation coefficient for laboratory data and bivariable analysis for mortality and/or need for intensive care were assessed. A minority of patients (18.6%) were obese, and most patients were non- or moderate-drinkers (88.5%). Liver function tests were altered in 62.4% of patients, and improved during follow-up. None of the seven patients with known chronic liver disease had liver decompensation. Only one patient developed acute liver failure. In patients with altered liver function tests, PaO2/FiO2 < 200 was associated with greater mortality and need for intensive care (HR 2.34, 95% CI 1.07–5.11,p = 0.033). To conclude, a high prevalence of altered liver function tests was noticed in Italian patients with COVID-19, and this was associated with worse outcomes when developing severe acute respiratory distress syndrome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (37)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....